Journals / Anestezi Dergisi / 2003 / Cilt: 11 - Sayı: 2

The effects of sevoflurane and propofol on hepatic and renal fumctions in elderly patients

Yaşlı olgularda sevofluran ve propofolün karaciğer ve böbrek fonksiyonlarına etkisi

Pages
111–116
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result; we concluded that sevoflurane and propofol anesthesia in ASA I-II elderly cases undergoing elective surgery, renal functions were preserved for both of the groups, but although there was no statistically significant difference between two groups, minimal transient hepatic dysfunctions were signifantly more in sevoflurane group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, we aimed to compare the effects of sevoflurane and propofol on hepatic and renal f unctions in patients more than 65 years of age. 46 patients, ASA physical status I-II, more than 65 years of age, undergoing elective surgery were taken into the study.
📊
Key Findings & Data:Anaesthesia was induced with 66% N2O and 7% sevoflurane in the group S (n=23) and iv. 1-2 mg $kg^-1$ propofol approximately within 30 seconds in the group P (n=23).
💡
Conclusion & Impact:As a result; we concluded that sevoflurane and propofol anesthesia in ASA I-II elderly cases undergoing elective surgery, renal functions were preserved for both of the groups, but although there was no statistically significant difference between two groups, minimal transient hepatic dysfunctions were signifantly more in sevoflurane group.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Eterler · Yaşlı · Anestezikler

Abstract

In this study, we aimed to compare the effects of sevoflurane and propofol on hepatic and renal f unctions in patients more than 65 years of age. 46 patients, ASA physical status I-II, more than 65 years of age, undergoing elective surgery were taken into the study. Anaesthesia was induced with 66% N2O and 7% sevoflurane in the group S (n=23) and iv. 1-2 mg $kg^-1$ propofol approximately within 30 seconds in the group P (n=23). Anesthesia was maintained with 1-4% sevoflurane and 66% N2O in group S,2 -10 m $kg^-1$ $hr^-1$ propofol and 66% N2O in group P. Blood sample was taken from all patients preoperatively and postoperative 1, 3, 5-7 and 14. days to measure the total bilirubine (T.Bil.), aspartate aminotransferase (AST), g-glutamyl transferase (GGT), lactate dehydrogenase (LDH), alkalane phosphatase (ALP), creatinine (ere) and blood urea nitrogen (BUN). At the same time periods, creatinine clearences (K.Klr) were calculated, and protein and glucose qualitative analyses were done in urine. In Group S, AST and GGT at all postoperative periods, ALT and LDH in postoperatively 1 and 5-7th days, ALP and K.Klr in postoperatively 3rd day were measured significantly higher than preoperative basal values. In Group P, T.bil in postoperati-ve 1st day, AST in postoperative 14th day, ALT and ALP at all postoperative periods, LDH in postoperative 1st and 3rd days were measured significantly higher than preoperative basal values. As a result; we concluded that sevoflurane and propofol anesthesia in ASA I-II elderly cases undergoing elective surgery, renal functions were preserved for both of the groups, but although there was no statistically significant difference between two groups, minimal transient hepatic dysfunctions were signifantly more in sevoflurane group.

Özet

Bu çalışmada 65 yaş üzerindeki olgularda sevofluran ve propofolün karaciğer ve böbrek fonksiyonları üzerine olan etkilerini karşılaştırmayı amaçladık. ASA l-ll grubunda, 65 yaş üzerinde, elektif cerrahi uygulanacak 46 olgu çalışmaya alındı. Anestezi indüksiyonu sevofluran grubunda (Grup S, n=23) %66 N2O içinde %7 sevofluran ile sağlanırken, propofol grubunda (Grup P, n=23) IV 1-2 mg $kg^-1$ propofol ile yaklaşık 30 sn de gerçekleştirildi. Anestezi idamesi Grup S'de %l-4 sevofluran ve %66 N2O, Grup P'de ise 2-10 mg $kg^-1$ $st^-1$ propofol ve %66 N2O ile sağlandı. Çalışmaya alınan tüm olgulardan, total bilirubin (T.bil), aspartat aminotransferaz (AST), alanin aminotransferaz (ALT), g-glutamil transpeptidaz (GGT), laktat dehidrogenaz (LDH), alkalen fosfataz (ALP), kreatinin (Krt) ve kan üre nitrojeni (BUN) ölçümleri için indüksiyondan hemen önce (preoperatif), postoperatif l, 3, 5-7 ve 14. günlerde kan alındı. Aynı dönemlerde kreatinin klirensi (K.Klr) hesaplandı, idrarda protein ve glukozun kalitatif analizleri yapıldı. Grup S'de; preoperatif değere göre AST ve GGT değerleri postoperatif tüm periyotlarda, ALT ve LDH postoperatif l ve 5-7. günlerde, ALP ve K.Klr postoperatif 3. günde anlamlı olarak daha yüksek bulundu (p<0.05). Grup P'de ise preoperatif değerlere göre T.bil postoperatif l. günde, AST postoperatif 14. günde, ALT ve ALP postoperatif tüm periyotlarda, LDH postoperatif l ve 3. günlerde anlamlı olarak daha yüksek bulundu (p<0.05). Sonuç olarak; ASA I-II, elektif cerrahi uygulanan yaşlı olgularda sevofluran ve propofol anestezisinde, her iki grupta da böbrek fonksiyonlarının korunduğu, karaciğer fonksiyonlarında ise, gruplar arasında istatiksel farklılık olmamakla birlikte, sevofluran kullanımında daha belirgin olmak üzere her iki grupta hafif derecede geçici bozulmalar olduğunu tespit ettik.

🔖

Cite This Article

BUT, A. K., DURMUŞ, M., KÖROĞLU, A., YÜCEL, A., ÜLGER, H., ERSOY, M. Ö. (2003). The effects of sevoflurane and propofol on hepatic and renal fumctions in elderly patients. Anestezi Dergisi, Cilt: 11 - Sayı: 2, 111–116. https://ajindex.com/articles/355289

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Raja SN, Haythornthwaite JA. Anesthetic management of the elderly: Measuring function beyond the immediate perioperative horizon. Anesthesiology 1999; 91:909-11
  2. Sielenkamper AW, Booke M. Anaesthesia and the elderly. Curr Opin Anaesthesiol 2001; 14:679-84
  3. DeBellis RJ, Smith BS. Drug dosing in critically ill patients with renal failure: A pharmacokinetic approach. J Int Care Med 2000; 6 (15):273-313
  4. Conzen P, Peter K. Inhalation anaesthesia at the extremes of age: geriatric anaesthesia. Anaesthesia 1995; 50:29-33
  5. Suttner SW, Schmidt CC, Boldt J, Hüttner I, Kumle B, Piper SN. Low-flow desflurane and sevoflurane anesthesia minimally affect hepatic integrity and function in elderly. Anesth Analg 2000; 91:206-12
  6. Nishiyama T, Yokoyama T, Hanaoka K. Liver and renal function after repeated sevoflurane or isoflurane anaesthesia. Can J Anaesth 1998; 45:789-93
  7. Iaizzo PA, Seewald MJ, Powis G, Phil D, Van Dyke RA. The effects of volatile anesthetics on Ca++ mobilization in rat hepatocytes. Anesthesiology 1990; 72:504-9
  8. Lind RC, Gandolfi AJ, Hall PM. Covalent binding of oxidative biotransformation intermediates is associated with halothane hepatotoxicity in guinea pigs. Anesthesiology 1990; 73:1208-13
  9. Nishiyama T, Yokoyama T, Hanaoka K. Liver function after sevoflurane or isoflurane anaesthesia in neurosurgical patients. Can J Anaesth 1998; 45:753-6
  10. Kharasch ED, Frink EJ, Artru A, Michalowski P, Rooke GA, Nogami W. Long-duration low-flow sevoflurane and isoflurane effects on postoperative renal and hepatic function. Anesth Analg 2001; 93:1511-20
  11. Nishiyama T, Yokoyama T, Hanaoka K. Effects of sevoflurane and isoflurane anesthesia on arterial ketone body ratio and liver function. Acta Anaesthesiol Scand 1999; 43:347-51
  12. Shichinohe Y, Masuda Y, Takahashi H. A case of postoperative hepatic injury after sevoflurane anesthesia. Jpn J Anesthesiol 1992; 41:1802-5
  13. Conzen PF, Vollmar B, Habazettl H, Frink EJ, Peter K, Messmer K. Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg 1992; 74:79-88
  14. Sato K, Kawamura T, Wakusawa R. Hepatic blood flow and function in elderly patients undergoing laparoscopic cholecystectomy. Anesth Analg 2000; 90:1198-202
  15. Murray JM, Trinick TR. Hepatic function and indocyanine green clearance during and after prolonged anaesthesia with propofol. BJA 1992; 69:643-4
  16. Chen TL, Wang MJ, Huang CH, Liu CC, Ueng TH. Difference between in vivo and in vitro effec